Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARISMA THERAPEUTICS INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CARM - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ -36.82M | $ 11.49M | 0 |
| 3/31/2025 | $ -47.14M | $ 7.77M | 0 |
| 12/31/2024 | $ -60.04M | $ 12.95M | 0 |
| 9/30/2024 | $ -68.35M | $ 43M | 0 |
| 6/30/2024 | $ -76.51M | $ 37.43M | 0 |
| 3/31/2024 | $ -79.08M | $ 62.73M | 0 |
| 12/31/2023 | $ -82.31M | $ 86.82M | 0 |
| 9/30/2023 | $ -62.97M | $ 106.74M | 0 |
| 6/30/2023 | $ -18.1M | $ 238.89M | 0 |
| 3/31/2023 | $ -7.9M | $ 227.44M | 0 |
Key Performance Insights, Last 5 Years
- CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) P/FCF stands at 0.
- Over the past 5 years, CARISMA THERAPEUTICS INC's average P/FCF has been 8.1.
- The median P/FCF for CARISMA THERAPEUTICS INC during this period was 8.1
- CARISMA THERAPEUTICS INC reached its highest P/FCF over the past 5 years at 11.46.
- The lowest P/FCF recorded by CARISMA THERAPEUTICS INC in the same timeframe 4.74
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for CARISMA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 143.57M ] / FCF [ $ -36.13M ]
(=) P/FCF [ 0 ] CARM - Price to Free Cash Flow, Last 5 years
4.74
Minimum
Dec 31, 2022
11.46
Maximum
Sep 30, 2022
8.1
Average
8.1
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.27 with a standard deviation of 12.87.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 59.21 |
| average | 18.27 |
| median | 14.72 |
| std | 12.87 |